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Gene expressionarkinson's disease (sPD) from expression of patient mitochondrial DNA (mtDNA)
in neural cells devoid of their own mtDNA, the “cybrid” model. In spite of reproducing several properties of
sPD brain, it remains unclear whether sPD cybrid cells reﬂect more complex sPD brain bioenergetic
pathophysiology. We characterized and correlated respiration of intact sPD cybrid cells with electron
transport chain (ETC) protein assembly, complex I ETC gene expression and ETC protein levels in sPD brain.
We also assayed expression for multiple ETC genes coded by mtDNA and nuclear DNA (nDNA) in sPD cybrid
cells and brain. sPD cybrid cells have reduced levels of mtDNA genes, variable compensatory normalization of
mitochondrial gene expression and show robust correlations with mitochondrial ETC gene expression in sPD
brains. Relationships among ETC protein levels predict impaired complex I-mediated respiration in sPD brain.
That sPD cybrid cells and sPD brain samples show very correlated regulation of nDNA and mtDNA ETC
transcriptomes suggests similar bioenergetic physiologies. We propose that further insights into sPD
pathogenesis will follow elucidation of mechanisms leading to reduced mtDNA gene levels in sPD cybrids.
This will require characterization of the abnormalities and dynamics of mtDNA changes propagated through
sPD cybrids over time.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Parkinson's disease (PD) is the most common neurodegenerative
movement disorder of adults, afﬂicts 1–2% of adults over 60 and is a
brain-wide disorder that begins preclinically with α-synuclein (+)
aggregates (“Lewy neurites”) in the dorsal medulla and olfactory bulb
years before the advent of similar pathology in substantia nigra [1–5].
The subsequent advance of pathology into substantia nigra and death
of nigral dopaminergic neurons produce the bradykinetic movement
disorder that is the basis for the presenting clinical phenotype. Most
but not all of PD symptomatic motor progression results from ongoing
death of these nigral neurons, with later neuropsychiatric deﬁcits
likely arising from further rostral spread of Lewy neuritic changes and
Lewy body formation [6,7].
Individual pigmented nigral neurons isolated with laser capture
microdissection demonstrate substantial bioenergetic deﬁciencies
that increase with aging [8,9] and appear worsened by PD [8]. The
percentage of nigral dopamine neurons with negative histochemicalille, VA 22908, USA. Tel.: +434
ll rights reserved.staining for cytochrome oxidase (CO) activity is increased ~3-fold in
PD brains [8], and these CO(−) nigral neurons have increased levels of
mtDNA carrying deletions several kilobases in size [9,10]. Although
these mtDNA deletions occurred in the same general “common” area
of the mitochondrial genome, each was unique in its boundaries,
which tended to have direct repeat sequence homologies [9,10]. These
genetic ﬁndings implicate progressive mtDNA damage as contributing
to the accelerated appearance of signiﬁcant bioenergetic deﬁciency in
PD neurons compared to that of normal aging. However, it is not yet
clear whether similar mtDNA deletions will be found in other
neuronal groups not as susceptible to degeneration as those in nigra.
We and others have explored the hypothesis that PD is a systemic
mitochondrial disorder that is expressed clinically in postmitotic,
energy intensive tissues like brain [11–13]. Mitochondria from multi-
ple PD tissues demonstrate bioenergetic deﬁciencies, with a common
ﬁnding being a reduction of activity of complex I in the electron
transport chain [14,15]. The complex I deﬁciency of catalytic activity is
partially transferable through cytoplasmic fusion with mitochondrial
transfer and mtDNA expression in cybrid cell models [16–18].
Multiple other abnormalities uncovered in PD cybrids, including
spontaneous formation of cytoplasmic inclusions with all discernible
characteristics of Lewy bodies [19], support the utility of the cybrid
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sPD cybrid nuclear and mitochondrial gene expression proﬁles
compared to that of sPD frontal cortex. We characterized with “high-
resolution respirometry” [20] the respiration properties of sPD cybrids
and examined the relationships among their respiration properties,
mitochondrial ETC gene expression and complex I assembly. We also
characterized the molecular genetic responses of sPD cybrids and sPD
brain. Our ﬁndings deﬁne similarities among sPD cybrid lines and sPD
brains, suggest future directions for investigations to increase under-
standing of sPD bioenergetics and support the use of sPD cybrids as
translational models for elucidating sPD pathogenesis.
2. Materials and methods
Detailed methods for cybrid creation, culture, differentiation into
neurons, RNA isolation and analyses, microarray hybridization and
analyses, real-time, quantitative PCR, Western blots and intact cell
respiration measurements are provided in Supplemental detailed
methods. Summary methods are as follows:
2.1. Cybrid creation and neuronal differentiation
Cybrid cell lines were created by fusing platelets from individuals
with idiopathic Parkinson's disease or disease-free controls with rho0
cells created in SH-SY5Y neuroblastoma cells by long-term exposure
to ethidium bromide to deplete selectively mitochondrial DNA
(mtDNA). Blood samples were collected under an IRB-approvedFig. 1. Relative levels of mtDNA genes in sPD and CTL cybrid gradient-puriﬁed mitochondri
analyzed with qPCR for mtDNA gene copy numbers. Data are expressed as percentages of meprotocol, and details of cybrid creation are provided elsewhere
[16,19,21]. Cybrid cell lines were routinely cultured in growthmedium
(GM), consisting of high glucose DMEM with 10% FBS, 100 μg/ml
pyruvate, 50 μg/ml uridine, and antibiotic-antimycotic: 100 U/ml
penicillin G, 100 μg/ml streptomycin, 0.25 μg/ml amphotericin β. Cells
were fed every 2–3 days and passed once a week. Gradient-puriﬁed
mitochondria were isolated from cybrid lines grown in bulk (20–26
T150 ﬂasks) and puriﬁed on Ficoll gradients. Cybrid cells were
differentiated into neurons by culturing in Neurobasal medium and
adding staurosporine at 6–10 nM.
2.2. Brain samples
Slow-frozen frontal cortical ribbon samples from neuropathologi-
cally conﬁrmed control and Parkinson's disease cases were obtained
from the University of Virginia Brain Resource Facility that collects
postmortem specimens under an IRB approved protocol. Tissue was
stored in air-tight containers at −70 °C from autopsy until time-of-use.
The samples used were part of a larger study involving characteriza-
tion of multiple aspects of mitochondrial function and ETC protein
biochemistry [22]. The ages at death and postmortem intervals were
not signiﬁcantly different among CTL and PD cases [22].
2.3. DNA and RNA extraction and analyses
DNA and RNA were extracted using Qiagen kits and manufac-
turer's instructions. RNA samples were analyzed for overall qualitya. Mitochondria from cybrid lines were puriﬁed on Ficoll gradients, DNA extracted and
an CTL copy numbers for each gene. Statistical signiﬁcances were determined by t-test.
Fig. 2. Comparison of mtDNA copy numbers for ETC genes with relative expression
levels of those mtDNA genes in sPD and CTL cybrid lines. mtDNA gene copy numbers
were derived as in Fig. 1 from DNA samples. Total RNA (1 μg) from each cybrid line was
reversed transcribed into cDNA and analyzed with qPCR for levels of mtDNA-encoded
genes. The method of Pfafﬂ [23] was used to calculate relative expression levels
compared to the CTL cybrids.
Fig. 3. (top) Correlation between mean relative expression levels of 10 mtDNA-
encoded genes determined by qPCR in samples from PD brain and PD cybrid neurons.
(bottom) Correlation between mean relative expression levels of 8 nDNA-encoded
mitochondrial ETC genes determined by qPCR in samples from PD brain and PD cybrid
neurons.
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All brain samples showed prominent 18S and 28S peaks and
variable degrees of degradation that was represented by several
small peaks. The mean+/−SD 28S/18S ratio for the 5 CTL brain
samples used was 0.90+/−0.30 (range 0.50–1.29) and for the ten PD
samples was 0.96+/−0.42 (range 0.52–1.35). For comparison, a
commercial RNA sample (Stratagene human RNA) analyzed on our
Experion system had a 28S/18S ratio of 1.31, and freshly isolated SH-
SY5Y RNA had a ratio of 1.27. DNA and RNA levels were assayed
with QuantIT kits.
2.4. Real-time, quantitative PCR (RT-qPCR)
Primers and TaqMan probes for mtDNA and nDNA-encoded ETC
genes were designed with Beacon Designer software. All qPCR assays
were carried out in an iQ5 instrument (BioRad) and used either primer
pairs with SyberGreen detection or multiplex PCR with TaqMan
probes. Relative gene expression was calculated with the method of
Pfafﬂ [23].
2.5. Respiration measurements
Cybrid cells were harvested with trypsin, counted and placed into
one of two chambers of an Oroboros Oxygraph II respirometer.
Respiration in intact cells metabolizing glucose in DMEM media was
assayed using the “high-resolution oximetry” approach [20]. All
respiration experiments used the same numbers of Trypan blue-
excluding live cells (typically 4.5 million cells/ml).
2.6. Cardiolipin assay
Cardiolipin is an abundant phospholipid in the inner mitochon-
drial membrane and was assayed as a marker for mitochondrial mass.
Cell or mitochondrial samples were sonicated and mixed withMitoTracker green and analyzed on a ﬂuorescent plate reader.
Cardiolipin external standards provided the standard curve.
2.7. Graphics and statistics
Data were graphed using Synergy KaleidaGraph and GraphPad
Prism, both for Macintosh. Statistical analyses used GraphPad InStat
for Macintosh. Correlation coefﬁcients were derived from linear
correlation curve ﬁtting. Populations were compared using either t-
tests for normally distributed data, or Mann–Whitney test for non-
normally distributed data, as determined by InStat.
3. Results
3.1. PD cybrids have reduced levels of mitochondrial gene DNAs and
variable normalization of mitochondrial genes' expression
We extracted DNA from gradient puriﬁed mitochondria isolated
from PD and CTL cybrids grown in bulk and assayed equal amounts
of these mtDNAs for levels of several mtDNA genes and D-loop
using qPCR. When expressed as percentages of mean CTL cybrid
levels, mtDNA genes (as DNA) from sPD cybrid mitochondria
showed consistent several fold reductions (Fig. 1). Overall the
proportion of reduction was fairly constant across different genes'
DNA levels.
We also determined relative expression levels of these genes in
cybrid cell lines' RNA samples treated with reverse transcriptase. We
followed the approach described by Pfafﬂ [23] to calculate gene
expression relative to mean CTL cybrid levels. Fig. 2 shows that for
ND4, CO1 and CO2 genes, the RNA levels in sPD cybrids approximated
those of CTL cybrids, even though there were substantial decreases in
Fig. 5. Distributions of maximal uncoupled complex I-mediated respiration in CTL and
sPD cybrids. See text for details.
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levels in four of the six sPD cybrids were lower than in CTL cybrids.
3.2. Expression of mtDNA-encoded genes is very highly correlated in PD
brain compared to PD cybrid neurons
Because the mtDNA 12S and 16S rRNA genes are independently
transcribed from their own transcription initiation site and made in
excess compared to the mtDNA-encoded ETC gene transcripts, we
used the level of 12S rRNA expression as a normalizing factor across
samples, which thus represents the averaged relative expression
levels from 9 PD and 4 CTL cybrid neurons, and 10 PD and 5 CTL brain
samples.
The relative expression levels of mtDNA encoded genes in PD brain
and PD cybrid neurons are shown in Supplemental spreadsheet ﬁle
“ETC Expression.xls”. Therewere no statistically signiﬁcant differences
for individual mtDNA-encoded genes between PD and CTL in either
group (brain or cybrid neurons). However, Fig. 3 (top) shows that there
was a very high correlation between averaged relative expression
levels for 10 mtDNA-encoded genes in PD brain samples compared to
PD cybrids, with a correlation coefﬁcient (R) of 0.91.
Supplemental Table 1 shows that in the PD brain and cybrid
neuron samples therewas a high degree of cross correlation of relative
expression levels of the mtDNA-encoded genes. This ﬁnding is
consistent with current views about mtDNA transcription, in that
the individual genes are transcribed as part of a large polycistron that
is then processed into individual rRNAs, tRNAs or coding mRNAs for
gene translation [24]. All coding genes are believed to arise from
transcription of the mtDNA heavy strand, with the exception of ND6
that is transcribed off the mtDNA light strand.
3.3. Expression of nDNA-encoded mitochondrial ETC genes is also very
highly correlated in PD brain compared to PD cybrid neurons
Approximately 74 out of 87 mammalian electron transport chain
(ETC) proteins are coded for by the nuclear genome, with the protein
products imported into mitochondria and assembled with the 13
mtDNA-encoded ETC proteins to form a functional respiratory chain.
In light of our observation above that showed such a high correlation
between PD brain and PD cybrid neurons among mtDNA-encoded
genes' expression, we next examined expression levels of eight nDNA-
encoded complex I and complex IV ETC genes (data in “ETC
Expression.xls”). As shown in Fig. 3 (bottom), there was a very high
correlation (R=0.95) among averaged relative expression levels for
eight nDNA-encoded ETC genes between PD cybrid neurons and PD
brain samples.Fig. 4. Correlations between sPD and CTL cybrid cell oxygen consumption rates normalized to
basal respiration of intact cells metabolizing glucose (R=0.88), and that on the right shows3.4. Complex I-mediated respiration in cybrids is related to expression of
complex I genes and levels of functionally assembled complex I
Using an Oroboros Oxygraph II respirometer and the “high-
resolution respirometry” approach devised by Gnaiger et al. [20] we
studied respiration in intact sPD and CTL cybrid cells metabolizing
glucose. Cybrid cells at 80–90% conﬂuence were harvested using
trypsin, and equal numbers of trypan blue-excluding live cells were
suspended in glucose-DMEM, placed into the calibrated Oxygraph
chambers and saturated with room air. Basal respiration rate was then
measured, followed by ATP synthase inhibition with oligomycin,
stepwise uncoupling with multiple FCCP injections, inhibition of
maximum uncoupled respiration with rotenone to determine the
complex I-mediated component, followed by additions of antimycin
A/myxothiazole to determine the component mediated by complexes
II/III. With this approach, the mitochondrial contribution to the
complex cellular control of respiration can be evaluated with all
metabolic feedback systems in place in neural cells metabolizing
glucose, the usual substrate for neuronal metabolism.
We developed an assay for mitochondrial cardiolipin, an abundant
phospholipid in the inner mitochondrial membrane, as a marker for
relative mitochondrial mass. In comparing our sPD to CTL cybrid cells,
we found no difference between the ratios of mg mitochondrial
cardiolipin content to mg cell protein (CTL=57.8+/−13.5 (SD);
sPD=60.6+/−11.6 (SD)), indicating that relative mitochondrial mass
was the same in the sPD and CTL cybrid cells.numbers of live cells compared to μg of cardiolipin present. The graph on the left shows
rotenone-sensitive maximal FCCP-uncoupled respiration (R=0.96).
Fig. 6. Relationship in CTL and sPD cybrid cells between levels of the ~900 kDa complex
I macroassembly assayed with blue-native gel electrophoresis and normalized to levels
of the outer mitochondrial membrane protein porin, compared to maximal complex I-
mediated uncoupled respiration. R=0.69.
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respiration rates normalized to either numbers of live cells or
mitochondrial cardiolipin content in both sPD and CTL cybrids is
shown in Fig. 4. Both relationships were highly linear. The respiratory
control ratios (maximum FCCP uncoupled respiration/basal respira-
tion in presence of oligomycin) were 4.23+/−1.45 (SD) in CTL cybrid
lines (n=5) and 3.57+/−1.67 in PD cybrid lines (n=7). The two groups
were not signiﬁcantly different from each other (P=0.55, two-tailed t-
test), indicating similar degrees of ETC coupling.
Fig. 5 shows that there was a non-signiﬁcant trend (p=0.24) for
reduction of maximal complex I-mediated respiration in sPD
compared to CTL cybrids. We then examined the relationship between
maximal complex I-mediated respiration rate in intact sPD and CTL
cybrid cells and the levels of fully assembled ~900 kDa complex I as
assayed with blue-native (B-N) gel electrophoresis. We normalized
the relative levels of B-N complex I to those of porin (a.k.a. voltage
dependent anion channel, VDAC), a marker for mitochondrial outer
membrane. As shown in Fig. 6 there was a moderately strongFig. 7. Inter-relationships among complex I-mediated sPD cybrid respiration, complex I gen
detected with the MS109 antibody from Mitosciences (see Supplemental Fig. 1 and [22]). Su
respiration and 8 kDa protein levels (normalized tomitoﬁlin) in gradient-puriﬁedmitochond
protein levels in gradient-puriﬁed mitochondria from sPD brains and mtDNA-encoded com
shows the relationship between mtDNA-encoded complex I gene relative expression in sPD
analysis.correlation (R=0.69) between maximal complex I-mediated respira-
tion rates in eleven cybrid cell lines metabolizing glucose and their
relative levels of fully assembled complex I.
3.5. Complex I-mediated respiration in PD brain may be reduced based
on relationships among complex I gene expression and protein levels in
PD brains and PD cybrids
Because it is not possible to reliably measure coupled mitochon-
drial respiration in frozen postmortem brain specimens, we sought to
develop a syllogistic argument relating complex I-mediated respira-
tion in PD cybrids to respiration that could be predicted to occur in PD
brain. The data used for this argument are shown in Fig. 7. In part 7A
we show that maximum complex I-mediated respiration in PD cybrids
correlates well (R=0.88) with levels of the 8 kDa complex I protein
that we showed previously were reduced in gradient-puriﬁed PD
brain mitochondria and correlated in those mitochondria with
reduced rates of NADH-driven electron ﬂow through complex I [22].
In part 7B we show that the levels of this 8 kDa complex I protein in
those sPD brain mitochondria correlate with levels of sPD brain
complex I gene expression determined in the present study. The
correlation coefﬁcients range from a low of 0.78 for ND5 to a high of
0.88 for ND2. In part 7C we show that the mean relative expression
levels of ﬁve out of the six mitochondrial complex I genes in sPD
brains assayed in the present study correlate strongly with those
found in sPD cybrids.
4. Discussion
In the present study we have developed the argument that cybrid
cells expressing platelet mtDNA from subjects with sporadic PD are
meaningful models of some molecular events in sPD brains and
predict reduced complex I-mediated respiration in sPD brain. This
argument is based on strong correlations among relative expression
levels of genes for mitochondrial ETC proteins coded for by both the
nuclear and mitochondrial genomes and inter-relationships among
cybrid complex I-mediated respiration, levels of an 8 kDa complex I
protein that discriminates sPD from CTL brain mitochondria and
expression levels for multiple mtDNA-derived complex I genes. Our
ﬁndings complement those recently described in sPD cybrids createde expression in sPD cybrids and sPD brains and levels of the 8 kDa complex I protein
bpanel A shows the relationship in sPD cybrids between maximal complex I-mediated
ria from these cells; R=0.88). Subpanel B shows the relationships among 8 kDa complex I
plex I gene expression in the sPD brain samples; R varies from 0.78 to 0.88. Subpanel C
cybrid cells compared to sPD brain. The outlier ND4 was not included in the regression
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that sPD cybrids had reduced complex I catalytic activity, less basal
ATP and greater progression into mitochondrial cell death.
In an earlier study we showed that the complex I macroassembly
immunocaptured from mitochondria that had been gradient-puriﬁed
from the same PD brain cases used in the present study showed
increased oxidative damage and reduced rates of NADH-driven
electron ﬂow [22]. We also showed how some of the protein oxidative
damage could originate within complex I. These ﬁndings are
consistent with the concept that PD brain complex I proteins become
oxidatively damaged more than age-matched controls through
unclear mechanisms, with the end result of reduced complex I
electron passage capacity that could itself contribute to additional
oxidative damage.
Because coupled mitochondrial respiration cannot be reliably
assayed in frozen postmortem tissue, we examined this physiological
process in intact sPD cybrid cells metabolizing glucose. The “high-
resolution respirometry” approach studies respiration under regu-
lated conditions and provides understanding of respiratory coupling
and control when all metabolic feedback systems are operative in
intact cells [20]. This is a different situation compared to isolated
mitochondria or permeabilized cells, where speciﬁc electron transport
complex substrates are provided and maximal respiration under
conditions of minimal (state 4) or maximal (state 3) ATP synthesis is
measured. We have recently completed and will be reporting
separately a study in which intact cybrid cell respiration, including
its oxygen concentration–response [26], was compared to that of
gradient-puriﬁed mitochondria isolated from the same cybrid cells.
We observed similarities and some signiﬁcant differences, including
in isolated mitochondria the ability to stimulate substantial respira-
tion through complex II that is minimally present in intact cells where
the vast majority of respiration is mediated through complex I.
In the present study we related sPD cybrid maximal complex I-
mediated uncoupled respiration in intact cells to levels of fully
assembled complex I and to levels of 8 kDa complex I subunit in the
cybrids, to PD brain through the intermediaries of levels of RNAs
(cDNAs) for mtDNA-encoded complex I genes and their relationship to
levels of the same 8 kDa complex I subunit in PD brain mitochondria.
While our approach is necessarily correlational and is consistent with
but cannot prove that PD brain complex I-mediated respiration is
reduced, we feel the results are supportive of the argument.
Although maximal complex I catalytic activity is reduced in many
PD tissues including brain, it is unclear if such reductions in catalytic
activity necessarily reduce respiratory capacity or instead serve as
markers for inefﬁcient electron ﬂow that yields increased oxidative
stress. Our ﬁndings suggest that this reduced complex I catalytic
activity in sPD brain likely produces respiratory compromise, at least
in terms of ability to engage in oxidative phosphorylation, in addition
to whatever oxidative stress also results.
We also observed that sPD cybrid cells have several-fold reductions
in multiple mtDNA genes. It is unclear why this is the case, but it
suggests that sPD mtDNA is not propagated as well as CTL mtDNA in
genetically identical host cells. There are many potential causes for
this problem that can include oxidative damage to the speciﬁc mtDNA
replicating DNA polymerase-gamma, defective replication due to
deletions in mtDNA and stalling of replication forks, increased
oxidative damage to mtDNA, or combinations of these and other
processes. An important starting point is analysis of characteristics of
sPD cybrid mtDNA itself. We have begun such analyses in terms of
quantifying deletions present in the entire mitochondrial genome and
presence of heteroplasmic mutations and will be reporting those
ﬁndings separately (Quigley, et al., unpublished data).
In spite of reductions in mtDNA gene levels, sPD cybrids were able
to normalize (to CTL levels) many but not all of their RNA levels for
these mtDNA genes. Of the ﬁve mtDNA genes we examined, three
(ND4, CO1, CO2) were normalized and two (ND2, CO3) were notnormalized in four of the six sPD cybrid lines studied. Of these four
sPD cybrid lines with the non-normalized ND2 and CO3 gene
expression, three had the lowest respiration levels. Thus, reduced
respiration in sPD cybrids relates to both overall loss of mtDNA genes
and failure to normalize mitochondrial gene expression at the RNA
level, at least for some mitochondrial genes. The mechanisms for how
mtDNA gene expression is differentially regulated in these sPD cybrid
lines are unclear.
In summary, we have conducted extensive analyses of the
molecular genetic properties of sPD cybrids and compared those to
sPD brains. We ﬁnd substantial correlations of gene expression,
particularly for both nuclear and mitochondrial genome-encoded
electron transport chain genes, which indicate that sPD cybrids and
sPD brains are regulating gene expression for mitochondrial respira-
tory function in very similar ways. Based on correlations with
mitochondrial gene expression and complex I protein levels, respira-
tion through complex I in intact sPD cybrid cells may relate to that of
sPD brain. If true, sPD cybrids can serve as unique genetic models of
sPD to assist both in unraveling howabnormalities inmtDNA originate
and progress, and to screen therapeutics for their ability to enhance
respiration through complex I. However, to consider properly the
inherent heterogeneity of a sporadic disease, several different cell
lines would need to be studied.
It is also important to note that most sPD postmortem brain tissues
are derived from individuals who suffered from PD for many years and
typically have advanced disease clinically and pathologically. In
contrast, sPD cybrids are made from platelet mtDNA of patients
typically at much earlier disease state. While the relationships
between platelet and brain mtDNAs are not yet known, at the
minimum sPD cybrids represent an earlier disease stage compared to
most postmortem sPD brain tissues. Given this situation, our ﬁndings
that sPD cybrids and sPD brain tissues so closely co-regulate their
mitochondrial bioenergetic systems are all the more remarkable.
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